Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Razoxane poisoning |
Causative agent (attribute) |
True |
Razoxane (substance) |
Inferred relationship |
Some |
1 |
Accidental razoxane poisoning |
Causative agent (attribute) |
False |
Razoxane (substance) |
Inferred relationship |
Some |
|
Intentional razoxane poisoning |
Causative agent (attribute) |
False |
Razoxane (substance) |
Inferred relationship |
Some |
|
intoxication par le razoxane d'intention indéterminée |
Causative agent (attribute) |
False |
Razoxane (substance) |
Inferred relationship |
Some |
1 |
Razoxane adverse reaction |
Causative agent (attribute) |
True |
Razoxane (substance) |
Inferred relationship |
Some |
1 |
Allergy to razoxane (finding) |
Causative agent (attribute) |
False |
Razoxane (substance) |
Inferred relationship |
Some |
|
Razoxane overdose |
Causative agent (attribute) |
True |
Razoxane (substance) |
Inferred relationship |
Some |
1 |
Accidental razoxane overdose |
Causative agent (attribute) |
True |
Razoxane (substance) |
Inferred relationship |
Some |
1 |
Intentional razoxane overdose (disorder) |
Causative agent (attribute) |
True |
Razoxane (substance) |
Inferred relationship |
Some |
1 |
surdose de razoxane d'intention indéterminée |
Causative agent (attribute) |
False |
Razoxane (substance) |
Inferred relationship |
Some |
1 |
Razoxane 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Razoxane (substance) |
Inferred relationship |
Some |
|
Product containing razoxane (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Razoxane (substance) |
Inferred relationship |
Some |
1 |
Dexrazoxane hydrochloride 250mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Razoxane (substance) |
Inferred relationship |
Some |
|
Dexrazoxane hydrochloride 500mg/vial powder |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Razoxane (substance) |
Inferred relationship |
Some |
|
Dexrazoxane hydrochloride |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Razoxane (substance) |
Inferred relationship |
Some |
|
Accidental razoxane poisoning |
Causative agent (attribute) |
True |
Razoxane (substance) |
Inferred relationship |
Some |
1 |
Intentional razoxane poisoning |
Causative agent (attribute) |
True |
Razoxane (substance) |
Inferred relationship |
Some |
1 |
Allergy to razoxane (finding) |
Causative agent (attribute) |
True |
Razoxane (substance) |
Inferred relationship |
Some |
1 |
Razoxane 125 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Razoxane (substance) |
Inferred relationship |
Some |
1 |
Razoxane 125 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Razoxane (substance) |
Inferred relationship |
Some |
1 |
Razoxane 125 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Razoxane (substance) |
Inferred relationship |
Some |
1 |
Razoxane-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Razoxane (substance) |
Inferred relationship |
Some |
1 |
Razoxane only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Razoxane (substance) |
Inferred relationship |
Some |
1 |
Product containing only razoxane in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Razoxane (substance) |
Inferred relationship |
Some |
1 |